Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office

UA COVID-19 National Registry: National Registry of Pediatric Cancer Patients Diagnosed with COVID-19

Clinical Trial Details

This is an observational study that will collect data from oncology patients diagnosed with COVID-19 including their demographics, diagnosis, stage of treatment, symptom presentation, severity of disease, COVID-19 directed treatment and impact on cancer care.

The purpose is to describe and disseminate, in real time, the evolving clinical course of children, adolescents, and young adults diagnosed with cancer and infected with SARS-COV-2 and/or who have received a COVID-19 vaccine via a national database registry.

After consenting to participate in this study, data will be collected from patient records. Participants do not need to come into the office or take any other action.  

Key Eligibility: 
  1. Between the ages of 0-39
  2. Diagnosis of a malignant neoplasm
  3. Currently receiving cancer directed therapy, including chemotherapy, radiation therapy, immunotherapy or status/post hematopoietic stem cell transplant
  4.  Diagnosis of COVID-19 by PCR testing or serologic testing demonstrating antibodies against corona virus and/or administration of a COVID-19 vaccine

Detailed eligibility requirements will be reviewed with the study team.

Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

Lisa Bayer, NP
(212) 746-3413
lbayer@med.cornell.edu

Primary Investigator(s)

Alexander Ja-Ho Chou, MD

Protocol ID(s)

Weill Cornell Medicine IRB #:

2006022227

Status

Open to Enrollment

Age Group

Adult

Sponsor

  • University of Alabama

Disease

COVID-19